Audent Global Asset Management LLC Sells 9,432 Shares of iShares Biotechnology ETF $IBB

Audent Global Asset Management LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 38.3% during the first quarter, Holdings Channel.com reports. The firm owned 15,185 shares of the financial services provider’s stock after selling 9,432 shares during the period. iShares Biotechnology ETF accounts for about 2.7% of Audent Global Asset Management LLC’s portfolio, making the stock its 14th largest position. Audent Global Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $2,564,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at about $26,000. Cary Street Partners Financial LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth about $29,000. Copia Wealth Management bought a new stake in iShares Biotechnology ETF during the 4th quarter worth about $34,000. Finally, Caitlin John LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter worth about $34,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $189.76 on Friday. iShares Biotechnology ETF has a 1-year low of $128.84 and a 1-year high of $199.05. The firm has a 50-day moving average price of $177.79 and a two-hundred day moving average price of $173.40.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.